Signal Transduction in the Cardioprotective Effect of Alcohol
酒精心脏保护作用中的信号转导
基本信息
- 批准号:10670683
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Epidemiologic studies have shown that light to moderate ethanol use is associated with a protective effect against fatal coronary artery disease. We showed that the cardioprotective effect of ethanol requires adenosine A1 receptor activation at the time of ischemia, like experimental ischemic preconditioning (PC). We investigated the potential downstream mediators of this protection, compared with PC.[1] Is ethanol's protective effect abolished by PKC inhibitor, chelerythrine? 2. Are α,δandεprotein kinase C(PKC) translocated in myocytes from ethanol exposed hearts versus controls, like PC? (1) The improved contradtile recovery by ethanol was abolished by chelerythrine. (2) Western blot analysis and immunofluorescence localization demonstrate that regular ethanol consumption causes sustained translocation of εPKC, but not δor αPKC. This same enzyme is directly implicated in PC's protection against ischemia-reperfusion injury. These findings suggest (i) that regular ethanol consumption induces long-term cardioprotection through sustained translocation of εPKC and (ii) that PKC activity is necessary at the time of ischemia to mediate ethanol's protective effect.[2] Is the cardioprotective effect mediated by species-specific signaling like PC? Adenosine receptor blockade abolished ethanol's protection in guinea pig but not rat hearts. By contrast, α1-adrenergic blockade abolished ethanol's protection in rat but not guinea pig hearts. These finding are similar to PC.[3] Is phospholipase C(PLC) involved in the cardioprotective effect of ethanol? PLC blockade abolished ethanol's protection in guinea pig hearts, similar to PC.These results suggest that the cardioprotective effect of alcohol can be used for clinical application as a chronic ischemic preconditioning.
流行病学研究表明,光到中度乙醇的使用与针对致命冠状动脉疾病的保护作用有关。我们表明,乙醇的心脏保护作用需要在缺血时腺苷A1受体激活,例如实验性缺血性预处理(PC)。与PC相比,我们研究了该保护的潜在下游介质。[1] PKC抑制剂Chelerythrine是否废除了乙醇的保护作用? 2。是否在乙醇暴露的心脏与对照(如PC)中翻译在肌细胞中的α,ΔANDεPROTEIN激酶C(PKC)? (1)Chelerythrine废除了乙醇的矛盾恢复的改善。 (2)Western印迹分析和免疫荧光定位表明,常规乙醇消耗会导致εpkc的持续易位,但不会导致ΔORαPKC。同样的酶直接与PC防御缺血再灌注损伤有关。这些发现表明(i)常规的乙醇消耗通过εPKC的持续易位诱导长期心脏保护,并且(ii)在缺血时需要PKC活性来介导乙醇的保护作用。[2] [2]心脏保护作用是否由PC(例如PC)特定于规格的信号介导?腺苷接收器封锁废除了几内亚猪的乙醇保护,而不是大鼠的心。相比之下,α1-肾上腺素阻塞废除了大鼠但豚鼠心脏中的乙醇保护。这些发现与PC相似。[3]磷脂酶C(PLC)是否参与乙醇的心脏保护作用? PLC封锁废除了类似于PC的豚鼠心中乙醇的保护。这些结果表明,酒精的心脏保护作用可用于临床应用,作为慢性缺血预处理。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Masami Miyamae: "Blockade of ATP sensitive potassium channels attenuates preconditioning effect of myocardial metabolism in swine"International Journal of Cardiology. 67. 225-236 (1998)
Masami Miyamae:“阻断 ATP 敏感钾通道会减弱猪心肌代谢的预处理作用”国际心脏病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Masami Miyamae: "Alcohol consumption reduces ischemia-reperfusion injury by species-specific signaling in guinea pigs and rats" American Journal of Physiology. 275(44). H50-H56 (1998)
Masami Miyamae:“饮酒通过豚鼠和大鼠的物种特异性信号传导减少缺血再灌注损伤”美国生理学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MIYAMAE Masami其他文献
MIYAMAE Masami的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MIYAMAE Masami', 18)}}的其他基金
The role of autophagy in cardioprotection by volatile anesthetics
自噬在挥发性麻醉药心脏保护中的作用
- 批准号:
23593008 - 财政年份:2011
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The mechanisms of enhanced cardioprotection by combination of volatile anesthetics and moderate alcohol consumption
挥发性麻醉药与适量饮酒联合增强心脏保护的机制
- 批准号:
20592382 - 财政年份:2008
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Involvement of apoptosis in the cardioprotective effect of volatile anesthetics
细胞凋亡参与挥发性麻醉药的心脏保护作用
- 批准号:
18592210 - 财政年份:2006
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal transduction in the cardioprotective effect of volatile anesthetics
挥发性麻醉药心脏保护作用中的信号转导
- 批准号:
16592032 - 财政年份:2004
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Signal Transduction in the Cardioprotective Effect of Light Alcohol and its clinical application for ischemic preconditioning
淡醇心脏保护作用中的信号转导及其缺血预处理的临床应用
- 批准号:
12670706 - 财政年份:2000
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
m6A甲基化修饰FDX1介导铜死亡参与心肌缺血再灌注损伤的机制研究
- 批准号:82302465
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于TRIM27/MST4/ATG4B通路激活自噬流减轻肠缺血再灌注损伤致肠屏障功能障碍的机制研究
- 批准号:82302467
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
神经干细胞外泌体传递YBX1调控ANXA2稳定性缓解脑缺血再灌注损伤机制研究
- 批准号:82360386
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
RNA甲基化转移酶METTL7B介导lncRNA-MIR22HG的m6A修饰促进脑缺血再灌注损伤的机制研究
- 批准号:82301476
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
15-脂氧合酶及其代谢产物15-HpETE在缺血再灌注损伤诱发心肌细胞铁死亡过程中的调控作用和机制研究
- 批准号:82370295
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
- 批准号:
10901520 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
N-acetylserotonin alleviates neurotoxicity in alcohol misuse following TBI
N-乙酰血清素可减轻 TBI 后酒精滥用造成的神经毒性
- 批准号:
10591834 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
- 批准号:
10412366 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Alcohol-induced Gut Dysbiosis and Cardiovascular Disease
酒精引起的肠道菌群失调和心血管疾病
- 批准号:
10616789 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别: